Automatic Classification of Sarcopenia Level in Older Adults: A Case Study at Tijuana General Hospital
- PMID: 31489909
- PMCID: PMC6765933
- DOI: 10.3390/ijerph16183275
Automatic Classification of Sarcopenia Level in Older Adults: A Case Study at Tijuana General Hospital
Abstract
This paper presents a study based on data analysis of the sarcopenia level in older adults. Sarcopenia is a prevalent pathology in adults of around 50 years of age, whereby the muscle mass decreases by 1 to 2% a year, and muscle strength experiences an annual decrease of 1.5% between 50 and 60 years of age, subsequently increasing by 3% each year. The World Health Organisation estimates that 5-13% of individuals of between 60 and 70 years of age and 11-50% of persons of 80 years of age or over have sarcopenia. This study was conducted with 166 patients and 99 variables. Demographic data was compiled including age, gender, place of residence, schooling, marital status, level of education, income, profession, and financial support from the State of Baja California, and biochemical parameters such as glycemia, cholesterolemia, and triglyceridemia were determined. A total of 166 patients took part in the study, with an average age of 77.24 years. The purpose of the study was to provide an automatic classifier of sarcopenia level in older adults using artificial intelligence in addition to identifying the weight of each variable used in the study. We used machine learning techniques in this work, in which 10 classifiers were employed to assess the variables and determine which would provide the best results, namely, Nearest Neighbors (3), Linear SVM (Support Vector Machines) (C = 0.025), RBF (Radial Basis Function) SVM (gamma = 2, C = 1), Gaussian Process (RBF (1.0)), Decision Tree (max_depth = 3), Random Forest (max_depth=3, n_estimators = 10), MPL (Multilayer Perceptron) (alpha = 1), AdaBoost, Gaussian Naive Bayes, and QDA (Quadratic Discriminant Analysis). Feature selection determined by the mean for the variable ranking suggests that Age, Systolic Arterial Hypertension (HAS), Mini Nutritional Assessment (MNA), Number of chronic diseases (ECNumber), and Sodium are the five most important variables in determining the sarcopenia level, and are thus of great importance prior to establishing any treatment or preventive measure. Analysis of the relationships existing between the presence of the variables and classifiers used in moderate and severe sarcopenia revealed that the sarcopenia level using the RBF SVM classifier with Age, HAS, MNA, ECNumber, and Sodium variables has 82'5 accuracy, a 90'2 F1, and 82'8 precision.
Keywords: diagnosis; machine learning; sarcopenia.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Evaluation of Prevalence of the Sarcopenia Level Using Machine Learning Techniques: Case Study in Tijuana Baja California, Mexico.Int J Environ Res Public Health. 2020 Mar 15;17(6):1917. doi: 10.3390/ijerph17061917. Int J Environ Res Public Health. 2020. PMID: 32183494 Free PMC article.
-
Statistical characterization and classification of colon microarray gene expression data using multiple machine learning paradigms.Comput Methods Programs Biomed. 2019 Jul;176:173-193. doi: 10.1016/j.cmpb.2019.04.008. Epub 2019 Apr 10. Comput Methods Programs Biomed. 2019. PMID: 31200905
-
Direct Kernel Perceptron (DKP): ultra-fast kernel ELM-based classification with non-iterative closed-form weight calculation.Neural Netw. 2014 Feb;50:60-71. doi: 10.1016/j.neunet.2013.11.002. Epub 2013 Nov 14. Neural Netw. 2014. PMID: 24287336
-
Predicting membrane protein types using various decision tree classifiers based on various modes of general PseAAC for imbalanced datasets.J Theor Biol. 2017 Dec 21;435:208-217. doi: 10.1016/j.jtbi.2017.09.018. Epub 2017 Sep 20. J Theor Biol. 2017. PMID: 28941868 Review.
-
Identifying Cancer Targets Based on Machine Learning Methods via Chou's 5-steps Rule and General Pseudo Components.Curr Top Med Chem. 2019;19(25):2301-2317. doi: 10.2174/1568026619666191016155543. Curr Top Med Chem. 2019. PMID: 31622219 Review.
Cited by
-
Performance Evaluation of Machine Learning Algorithms for Sarcopenia Diagnosis in Older Adults.Healthcare (Basel). 2023 Oct 9;11(19):2699. doi: 10.3390/healthcare11192699. Healthcare (Basel). 2023. PMID: 37830737 Free PMC article.
-
Associations between the Severity of Sarcopenia and Health-Related Quality of Life in Community-Dwelling Middle-Aged and Older Adults.Int J Environ Res Public Health. 2021 Jul 29;18(15):8026. doi: 10.3390/ijerph18158026. Int J Environ Res Public Health. 2021. PMID: 34360318 Free PMC article.
-
A systematic review of Machine Learning and Deep Learning approaches in Mexico: challenges and opportunities.Front Artif Intell. 2025 Jan 7;7:1479855. doi: 10.3389/frai.2024.1479855. eCollection 2024. Front Artif Intell. 2025. PMID: 39845096 Free PMC article. Review.
-
Impact of Glucose Profile, Fasting Insulin, and Renal Function on Sarcopenia in Elderly at Single Centered Nursing Home: A Cross-Sectional Structural Equation Model Analysis.J Multidiscip Healthc. 2025 Mar 6;18:1393-1404. doi: 10.2147/JMDH.S486370. eCollection 2025. J Multidiscip Healthc. 2025. PMID: 40066249 Free PMC article.
-
Towards Precision in Sarcopenia Assessment: The Challenges of Multimodal Data Analysis in the Era of AI.Int J Mol Sci. 2025 May 7;26(9):4428. doi: 10.3390/ijms26094428. Int J Mol Sci. 2025. PMID: 40362666 Free PMC article. Review.
References
-
- Goodpaster B.H., Park S.W., Harris T.B., Kritchevsky S.B., Nevitt M., Schwartz A.V., Simonsick E.M., Tylavsky F.A., Visser M., Newman A.B. The loss of skeletal muscle strength, mass, and quality in older adults: The health, aging and body composition study. J. Gerontol. A Biol. Sci. Med. Sci. 2006;61:1059–1064. doi: 10.1093/gerona/61.10.1059. - DOI - PubMed
-
- Espinel-Bermudez M., Sanchez-Garcia S., Garcia-Peña C., Trujillo X., Huerta-Viera M., Granados-Garcia V., Hernández-González S., Arias-Merino E.D. Associated factors with sarcopenia among Mexican elderly: 2012 National Health and Nutrition Survey. Rev. Med. Inst. Mex. Seguro Soc. 2018;56:46–53. - PubMed
-
- Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Michel J.P., Landi F., Martin F.C., Rolland Y., Schneider S.M., et al. Sarcopenia: Consenso europeo sobre su definición y diagnóstico informe del grupo europeo de trabajo sobre la sarcopenia en personas de edad avanzada. Age Ageing. 2010;39:412–423. doi: 10.1093/ageing/afq034. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources